The deadly disease of lung cancer is the leading cause of malignancy-related mortality worldwide owing to its diagnosis at a later stage. About 75% of those with lung cancer die within five…
Category: Lung Cancer News
Study Shows Circadian Rhythm Disruptions Linked To Enhanced Lung Cancer Growth
According to a new paper co-authored by University of Rochester Wilmot Cancer Institute investigator and led by the Scripps Research Institute in California, a vital molecular link is between growth of lung…
Electronic Nose to Detect Lung Cancer, Research Suggests
Research work and studies are continuously being done in the arena of lung cancer. Scientists and researchers continue to experiment new and effective ways to detect it at an early stage so…
Personalized Treatment for Small Cell Lung Cancer, MedUni Vienna Study Suggests
There are two main types of lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). SCLC is a particularly aggressive form of tumor and is mainly treated with…
Scientists Discover New Gene Target for Aggressive Small Cell Lung Cancer
Lung cancer is the leading cause of cancer deaths in the United States. According to the American Cancer Society, an estimated 131,880 lung cancer deaths are predicted for this year alone. Though…
Air Pollution Causes Lung Cancer among Non-Smokers, New Research Suggests
Although scientists have long known that air pollution is linked with an increased risk of lung cancer, but new research suggests one mechanism that might explain how air pollution may trigger lung…
Experimental Drug Treatment Stops Lung Cancer in Mice
Small cell lung cancer is one of the deadly diseases and now scientists may have promising new avenue as they have been able to effectively stop the growth of small cell lung…
FDA Grants Approval to Trastuzumab Deruxtecan for HER2 Lung Cancer
Lung cancer patients now have another treatment option. For those tumors carrying HER2 mutations, can now be treated with trastuzumab deruxtecan. This drug is already approved for use in HER2-positive breast cancer…